Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
SLC29A2 VHH recombinant monoclonal antibody
SLC34A2 VHH recombinant monoclonal antibody
SLC39A6 VHH recombinant monoclonal antibody
SLITRK6 VHH recombinant monoclonal antibody
SNCA VHH recombinant monoclonal antibody
SORT1 VHH recombinant monoclonal antibody
SOST VHH recombinant monoclonal antibody
SpA VHH recombinant monoclonal antibody
SSTR2 VHH recombinant monoclonal antibody
STAB1 VHH recombinant monoclonal antibody
STEAP1 VHH recombinant monoclonal antibody
TAG72 VHH recombinant monoclonal antibody